In the fast evolving subject of cancer therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is essential for developing helpful treatment options. Probably the most promising ways is using in vitro bystander outcome assays, which Participate in a pivotal position in boosting therapeutic efficacy. These assays, fur